Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 30

Related Articles by Review for PubMed (Select 20980638)

1.

Is soy consumption good or bad for the breast?

Hilakivi-Clarke L, Andrade JE, Helferich W.

J Nutr. 2010 Dec;140(12):2326S-2334S. doi: 10.3945/jn.110.124230. Epub 2010 Oct 27. Review.

2.

Protection against breast cancer with genistein: a component of soy.

Lamartiniere CA.

Am J Clin Nutr. 2000 Jun;71(6 Suppl):1705S-7S; discussion 1708S-9S. Review.

3.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

4.

Soy products in the management of breast cancer.

Magee PJ, Rowland I.

Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):586-91. doi: 10.1097/MCO.0b013e328359156f. Review.

PMID:
23075937
5.
6.

Epidemiologic studies of isoflavones & mammographic density.

Maskarinec G, Verheus M, Tice JA.

Nutrients. 2010 Jan;2(1):35-48. doi: 10.3390/nu2010035. Epub 2010 Jan 19. Review.

7.

The role of early life genistein exposures in modifying breast cancer risk.

Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L.

Br J Cancer. 2008 May 6;98(9):1485-93. doi: 10.1038/sj.bjc.6604321. Epub 2008 Apr 8. Review.

8.

Phytoestrogens: potential benefits and implications for breast cancer survivors.

Duffy C, Cyr M.

J Womens Health (Larchmt). 2003 Sep;12(7):617-31. Review.

PMID:
14583103
9.

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Messina M, McCaskill-Stevens W, Lampe JW.

J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84. Review.

10.

Soy intake and cancer risk: a review of the in vitro and in vivo data.

Messina MJ, Persky V, Setchell KD, Barnes S.

Nutr Cancer. 1994;21(2):113-31. Review.

PMID:
8058523
11.

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Messina M, Bennink M.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):707-28. Review.

PMID:
10384821
12.

Estrogen/isoflavone interactions in cynomolgus macaques (Macaca fascicularis).

Cline JM, Wood CE.

Am J Primatol. 2009 Sep;71(9):722-31. doi: 10.1002/ajp.20680. Review.

PMID:
19322873
13.

Soy intake and risk of breast cancer in Asians and Asian Americans.

Wu AH, Ziegler RG, Nomura AM, West DW, Kolonel LN, Horn-Ross PL, Hoover RN, Pike MC.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1437S-1443S. Review.

14.

Nutritional modulation of terminal end buds: its relevance to breast cancer prevention.

Hilakivi-Clarke L.

Curr Cancer Drug Targets. 2007 Aug;7(5):465-74. Review.

PMID:
17691906
15.

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.

Dong JY, Qin LQ.

Breast Cancer Res Treat. 2011 Jan;125(2):315-23. doi: 10.1007/s10549-010-1270-8. Epub 2010 Nov 27. Review.

PMID:
21113655
16.

Epidemiology of soy exposures and breast cancer risk.

Wu AH, Yu MC, Tseng CC, Pike MC.

Br J Cancer. 2008 Jan 15;98(1):9-14. doi: 10.1038/sj.bjc.6604145. Epub 2008 Jan 8. Review.

17.

Genistein studies in rats: potential for breast cancer prevention and reproductive and developmental toxicity.

Lamartiniere CA, Zhang JX, Cotroneo MS.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1400S-1405S. Review.

18.

Mechanisms of cancer chemoprevention by soy isoflavone genistein.

Sarkar FH, Li Y.

Cancer Metastasis Rev. 2002;21(3-4):265-80. Review.

PMID:
12549765
19.

The chemopreventive properties of soy isoflavonoids in animal models of breast cancer.

Barnes S.

Breast Cancer Res Treat. 1997 Nov-Dec;46(2-3):169-79. Review.

PMID:
9478272
20.

Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Messina MJ, Wood CE.

Nutr J. 2008 Jun 3;7:17. doi: 10.1186/1475-2891-7-17. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk